Key facts
- This page summarizes Tyler Lipschultz's Form 4 filing for SeaSpine Holdings Corp.
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Jul 2021, 19:08.
Tyler Lipschultz - 30 Jun 2021 Form 4 Insider Report for SeaSpine Holdings Corp
- Reporting relationship
- SVP, Orthobiologics and BD
- Issuer ticker
- N/A
- Reported as of
- 30 Jun 2021
- Net transaction value
- +$21,256
- SEC form
- 4
- Accepted by SEC
- 02 Jul 2021, 19:08:15 UTC
- Next SEC filing
- 04 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/Paul Benny, Attorney-in-Fact for Tyler Lipschultz
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Tyler Lipschultz filed Form 4 for SeaSpine Holdings Corp on 02 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$21,256.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SPNE
transaction
Common Stock
Other
- Transaction value
- $21,256
- Shares
- +2,383
- Change %
- +2.2%
- Price
- $8.92
- Shares after
- 112,467
- Date
- 30 Jun 2021
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c).
Footnote F2
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2020.